VIKING THERAPEUTICS INC (VKTX:NASDAQ)
$38.86 -2.28 (-5.5421%)
Analysed VIKING THERAPEUTICS INC (VKTX:NASDAQ) News Sources
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
07-07-2026
yahoo.com
VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?
08-07-2026
stocktwits.com
Why Viking Therapeutics (VKTX) Is Up 8.0% After Advancing New Obesity Drug VK3019 Into Phase 1 – And What's Next
08-07-2026
yahoo.com
Viking Therapeutics (VKTX) Could Be 120% Undervalued On Obesity Pipeline Progress
08-07-2026
yahoo.com
Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal
08-07-2026
yahoo.com
Viking Therapeutics (VKTX) Stock Looks Stretched After a 6x Five Year Run
08-07-2026
yahoo.com
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market Today
08-07-2026
yahoo.com
3 High Growth GLP-1 Biotech Winners to Buy in July
09-07-2026
247wallst.com
Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With STEP UP Data
09-07-2026
yahoo.com
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know
10-07-2026
yahoo.com
What is the current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The current price of VIKING THERAPEUTICS INC (VKTX:NASDAQ) is $38.86.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is $-2.28.
VIKING THERAPEUTICS INC (VKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of VIKING THERAPEUTICS INC (VKTX:NASDAQ) since the previous trading day is -5.5421%.
What is the most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent average sentiment score for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ)?
The most recent sentiment for VIKING THERAPEUTICS INC (VKTX:NASDAQ) is .
SEC-8K** Filing Available For VIKING THERAPEUTICS INC (VKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.